<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Augsburger, Fiona</dc:creator>
  <dc:creator>Szabo, Csaba</dc:creator>
  <dc:date>2020-04-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Hydrogen sulfide (H2S), produced by various endogenous enzyme systems,  serves various biological regulatory roles in mammalian cells in health and  disease. Over recent years, a new concept emerged in the field of H2S biology,  showing that various cancer cells upregulate their endogenous H2S production,  and utilize this mediator in autocrine and paracrine manner to stimulate  proliferation, bioenergetics and tumor angiogenesis. Initial work identified  cystathionine-beta-synthase (CBS) in many tumor cells as the key source of  H2S. In other cells, cystathionine-gamma-lyase (CSE) has been shown to play  a pathogenetic role. However, until recently, less attention has been paid to the  third enzymatic source of H2S, 3-mercaptopyruvate sulfurtransferase (3-MST),  even though several of its biological and biochemical features - e.g. its partial  mitochondrial localization, its ability to produce polysulfides, which, in turn, can  induce functionally relevant posttranslational protein modifications - makes it a  potential candidate. Indeed, several lines of recent data indicate the potential  role of the 3-MST system in cancer biology. In many cancers (e.g. colon  adenocarcinoma, lung adenocarcinoma, urothelial cell carcinoma, various forms  of oral carcinomas), 3-MST is upregulated compared to the surrounding normal  tissue. According to in vitro studies, 3-MST upregulation is especially prominent  in cancer cells that recover from oxidative damage and/or develop a multidrug- resistant phenotype. Emerging data with newly discovered pharmacological  inhibitors of 3-MST, as well as data using 3-MST silencing approaches suggest  that the 3-MST/H2S system plays a role in maintaining cancer cell proliferation;  it may also regulate bioenergetic and cell-signaling functions. Many questions  remain open in the field of 3-MST/cancer biology; the last section of current  article highlights these open questions and lays out potential experimental  strategies to address them.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/308379</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308379/files/sza_prt.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.phrs.2018.11.034</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Pharmacological Research. - 2020, vol. 154, p. 104083</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)—hydrogen sulfide (H2S) pathway in cancer cells</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
